Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001341642-26-000002
Filing Date
2026-03-09
Accepted
2026-03-09 16:35:20
Documents
1
Period of Report
2026-03-05

Document Format Files

Seq Description Document Type Size
1 form4-03092026_080314.html 4  
1 form4-03092026_080314.xml 4 3963
  Complete submission text file 0001341642-26-000002.txt   5407
Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address
Mack David Henry (Reporting) CIK: 0001341642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39539 | Film No.: 26735574

Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)